Tubulin polymerization-IN-41

Modify Date: 2025-08-25 20:31:30

Tubulin polymerization-IN-41 Structure
Tubulin polymerization-IN-41 structure
Common Name Tubulin polymerization-IN-41
CAS Number 2804026-81-9 Molecular Weight 435.26
Density N/A Boiling Point N/A
Molecular Formula C20H16Cl2N2O5 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Tubulin polymerization-IN-41


Tubulin polymerization-IN-41 is a potent tubulin polymerization inhibitor with the IC50 of 2.61 μM. Tubulin polymerization-IN-41 targets the Colchicine-binding site of tubulin. Tubulin polymerization-IN-41 has anticancer effects[1].

 Names

Name Tubulin polymerization-IN-41

 Tubulin polymerization-IN-41 Biological Activity

Description Tubulin polymerization-IN-41 is a potent tubulin polymerization inhibitor with the IC50 of 2.61 μM. Tubulin polymerization-IN-41 targets the Colchicine-binding site of tubulin. Tubulin polymerization-IN-41 has anticancer effects[1].
Related Catalog
In Vitro Tubulin polymerization-IN-41 (compound C3) displays remarkable antiproliferative activities with IC50 values of 6.3 nM, 9.2 nM, 8.3 nM, and 8.7 nM for K562, MCF-7, HT29, and HCT116 cells, respectively. Additionally, Tubulin polymerization-IN-41 shows marked activity against Paclitaxel-resistant MCF-7 cells and A549 cells[1]. Tubulin polymerization-IN-41 (compound C3; 5-20 nM) downregulates the expression of acetyl-α-tubulin (Ac-α-tubulin) and upregulated the expression of detyrosinated-α-tubulin (DeY-α-tubulin) in a concentration-dependent manner[1]. Tubulin polymerization-IN-41 (compound C3; 5-20 nM; 24 hours) could arrest cancer cells in the G2/M phase, and induces MCF-7 cells apoptosis in a concentration-dependent manner[1]. Tubulin polymerization-IN-41 (compound C3; 5-20 nM; 24 hours) reduces Ser216 phosphorylation, resulting in cdc2 Tyr15 dephosphorylation and Thr161 phosphorylation, which ultimately leads to the activation of subsequent cdc2/cyclin B1 complex[1]. Cell Cycle Analysis[1] Cell Line: MCF-7 cells Concentration: 5 nM, 10 nM, 20 nM Incubation Time: 24 h Result: Could arrest cancer cells in the G2/M phase. Apoptosis Analysis[1] Cell Line: MCF-7 cells Concentration: 5 nM, 10 nM, 20 nM Incubation Time: 24 h Result: Induced MCF-7 cells apoptosis. Western Blot Analysis[1] Cell Line: MCF-7 cells Concentration: 5 nM, 10 nM, 20 nM Incubation Time: 24 h Result: Induced cdc25c activation.
In Vivo Tubulin polymerization-IN-41 (compound C3; 5-20 mg/kg; i.p; every two days; for 21 consecutive days) exhibits the significant potency of tumor growth inhibition in a dose dependence without weight loss in the drug-treated period[1]. Animal Model: Five-week-old female athymic nude mice injected with MCF-7 cells[1] Dosage: 5, 10, and 20 mg/kg Administration: Intraperitoneal injection; every two days; for 21 consecutive days Result: Exhibited the significant potency of tumor growth inhibition in a dose dependence without weight loss in the drug-treated period.
References

[1]. Jiafu Leng, et al. Discovery of Novel N-Heterocyclic-Fused Deoxypodophyllotoxin Analogues as Tubulin Polymerization Inhibitors Targeting the Colchicine-Binding Site for Cancer Treatment. J Med Chem. 2022 Dec 22;65(24):16774-16800.  

 Chemical & Physical Properties

Molecular Formula C20H16Cl2N2O5
Molecular Weight 435.26
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.